Industry News
National analytical labs to merge
Three major federal analytical labs are to be merged from next July, when a National Measurement Institute will be formed from the amalgamation of the National Measurement Laboratory, the National Standards Commission and the Australian Government Analytical Laboratories. [ + ]
New project to tackle sheep genomics
In a simpler age, before molecular genetics, CSIRO researchers developed SireSine, a contraption containing a large, waterproof wax crayon strategically mounted around a ram's chest, that allowed him to sign off on the backs of obliging ewes. [ + ]
Biota in US agreement over SARS tests
Biota (ASX:BTA) has formed an agreement with two US government agencies -- the National Institute of Allergy and Infectious Diseases (NIAID) and the US Army Medical Research Institute of Infectious Diseases (USAMRIID) -- to test the company's antiviral compounds for activity against the SARS virus. [ + ]
Q-Pharm toasts success after first year in operation
Queensland's first Phase I clinical trials facility, Q-Pharm, has just celebrated its first birthday with almost 20 clinical trials under its belt already. [ + ]
Solagran claims success in liver disease drug trials
Botanical biotech Solagran (ASX: SLA) has announced success in preliminary trials of a bioeffective compound for the treatment of liver diseases. [ + ]
Epitan partners with pSivida in tanning drug project
A safe tan in a single injection is the aim of a new collaborative agreement between two Australian biotechnology companies. [ + ]
Peptech gets green light for dog contraceptive
Sydney peptide and protein therapeutics developer Peptech Ltd (ASX:PTD ) has announced that its fully owned subsidiary, Peptech Animal Health (PAH) has received approval to market its Suprelorin six-month contraceptive for dogs in Australia. [ + ]
Going for gold with nanotechnology
Collaborative nanotechnology research involving the University of Technology, Sydney has proved the value of gold as a vital component in the next generation of electronics.
[ + ]ATP Innovations signs MoU with CSU, Wagga Wagga
Technology business commercialisation centre ATP Innovations has entered an agreement with Charles Sturt University and Wagga Wagga City Council to help put research on the track to market. [ + ]
Blis Technologies aims at Chinese market
Dunedin (NZ) biotech company Blis Technologies has opened a portal into a potential $200 million market by signing a deal with Auckland-based Asia Pacific Biotech Distributors (APBD) to take its antibacterial Throat Guard into China. [ + ]
Acrux in major deal with Eli Lilly
Melbourne drug delivery systems developer Acrux has signed a major deal with global pharmaceutical group Eli Lilly and Company to commercialise its veterinary product line. [ + ]
New study to explore genetics of eczema
A tri-state research collaboration is set to use sibling pairs to examine the genetic reasoning behind the most common form of eczema [ + ]
CSIRO livestock researchers explore potential of new technologies
Two animal-virus hunters at CSIRO are exploring the potential of advanced genetic and proteomics technologies to make more accurate and rapid diagnoses of viral diseases and other microbial infections of livestock. [ + ]
Virax raises $3.4m
Development-stage biotechnology company Virax Holdings (ASX: VHL) has raised $3.4 million in a capital raising aimed to progress its prostate cancer and HIV drug development programs. [ + ]
New CEO at Peplin Biotech
Brisbane small molecule drug development company Peplin Biotech (ASX: PEP) today announced the appointment of its new chief executive. [ + ]
